Literature DB >> 22929972

Impact of FLT3 ITD/NPM1 mutation status in adult patients with acute myelocytic leukemia autografted in first remission.

Norbert-Claude Gorin1, Myriam Labopin, Giovanna Meloni, Arnaud Pigneux, Jordi Esteve, Mohty Mohamad.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22929972      PMCID： PMC3561443          DOI： 10.3324/haematol.2012.064436

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  12 in total

1.  Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study.

Authors:  Can-Lan Sun; Liton Francisco; Toana Kawashima; Wendy Leisenring; Leslie L Robison; K Scott Baker; Daniel J Weisdorf; Stephen J Forman; Smita Bhatia
Journal:  Blood       Date:  2010-07-23       Impact factor: 22.113

2.  Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remission.

Authors:  Norbert-Claude Gorin; Myriam Labopin; Josy Reiffers; Noel Milpied; Didier Blaise; Francis Witz; Theo de Witte; Giovanna Meloni; Michel Attal; Teresa Bernal; Vanderson Rocha
Journal:  Blood       Date:  2010-05-17       Impact factor: 22.113

Review 3.  Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity?

Authors:  Brunangelo Falini; Maria Paola Martelli; Niccolò Bolli; Paolo Sportoletti; Arcangelo Liso; Enrico Tiacci; Torsten Haferlach
Journal:  Blood       Date:  2010-10-28       Impact factor: 22.113

Review 4.  Autologous stem cell transplantation in acute myelocytic leukemia.

Authors:  N C Gorin
Journal:  Blood       Date:  1998-08-15       Impact factor: 22.113

5.  Prognostic impact of FLT3-ITD load in NPM1 mutated acute myeloid leukemia.

Authors:  S Schnittger; U Bacher; W Kern; T Alpermann; C Haferlach; T Haferlach
Journal:  Leukemia       Date:  2011-05-03       Impact factor: 11.528

6.  Favorable outcome in patients with acute myelogenous leukemia with the nucleophosmin gene mutation autografted after conditioning with high-dose continuous infusion of idarubicin and busulfan.

Authors:  Felicetto Ferrara; Tiziana Izzo; Clelia Criscuolo; Cira Riccardi; Giada Muccioli; Assunta Viola; Fabrizio Pane; Salvatore Palmieri
Journal:  Biol Blood Marrow Transplant       Date:  2010-02-19       Impact factor: 5.742

7.  Monitoring of minimal residual disease in NPM1-mutated acute myeloid leukemia: a study from the German-Austrian acute myeloid leukemia study group.

Authors:  Jan Krönke; Richard F Schlenk; Kai-Ole Jensen; Florian Tschürtz; Andrea Corbacioglu; Verena I Gaidzik; Peter Paschka; Shiva Onken; Karina Eiwen; Marianne Habdank; Daniela Späth; Michael Lübbert; Mohammed Wattad; Thomas Kindler; Helmut R Salih; Gerhard Held; David Nachbaur; Marie von Lilienfeld-Toal; Ulrich Germing; Detlef Haase; Hans-Günther Mergenthaler; Jürgen Krauter; Arnold Ganser; Gudrun Göhring; Brigitte Schlegelberger; Hartmut Döhner; Konstanze Döhner
Journal:  J Clin Oncol       Date:  2011-05-09       Impact factor: 44.544

8.  Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML).

Authors:  Christian Thiede; Sina Koch; Eva Creutzig; Christine Steudel; Thomas Illmer; Markus Schaich; Gerhard Ehninger
Journal:  Blood       Date:  2006-02-02       Impact factor: 22.113

9.  Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.

Authors:  Richard F Schlenk; Konstanze Döhner; Jürgen Krauter; Stefan Fröhling; Andrea Corbacioglu; Lars Bullinger; Marianne Habdank; Daniela Späth; Michael Morgan; Axel Benner; Brigitte Schlegelberger; Gerhard Heil; Arnold Ganser; Hartmut Döhner
Journal:  N Engl J Med       Date:  2008-05-01       Impact factor: 91.245

10.  Identical outcome after autologous or allogeneic genoidentical hematopoietic stem-cell transplantation in first remission of acute myelocytic leukemia carrying inversion 16 or t(8;21): a retrospective study from the European Cooperative Group for Blood and Marrow Transplantation.

Authors:  Norbert-Claude Gorin; Myriam Labopin; Francesco Frassoni; Noel Milpied; Michel Attal; Didier Blaise; Giovanna Meloni; Anna P Iori; Mauricette Michallet; Roel Willemze; Eric Deconninck; Jean-Luc Harousseau; Emmanuelle Polge; Vanderson Rocha
Journal:  J Clin Oncol       Date:  2008-05-27       Impact factor: 44.544
View more
  6 in total

1.  Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission.

Authors:  F Saraceni; B Bruno; R M Lemoli; G Meloni; W Arcese; M Falda; F Ciceri; E P Alessandrino; G Specchia; R Scimè; R Raimondi; A Bacigalupo; A Bosi; F Onida; A Rambaldi; F Bonifazi; A Olivieri
Journal:  Bone Marrow Transplant       Date:  2016-09-26       Impact factor: 5.483

2.  Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

Authors:  Arnon Nagler; Myriam Labopin; Norbert-Claude Gorin; Felicetto Ferrara; Miguel A Sanz; Depei Wu; Antonio Torres Gomez; Simona Lapusan; Giuseppe Irrera; Jose E Guimaraes; Aida Botelho Sousa; Angelo M Carella; Norbert Vey; William Arcese; Avichai Shimoni; Raanan Berger; Vanderson Rocha; Mohamad Mohty
Journal:  Haematologica       Date:  2014-05-09       Impact factor: 9.941

3.  Risk stratification using FLT3 and NPM1 in acute myeloid leukemia patients autografted in first complete remission.

Authors:  Roni Shouval; Myriam Labopin; David Bomze; Gabriela M Baerlocher; Saveria Capria; Didier Blaise; Mathias Hänel; Edouard Forcade; Anne Huynh; Riccardo Saccardi; Giuseppe Milone; Tsila Zuckerman; Péter Reményi; Jurjen Versluis; Jordi Esteve; Norbert Claude Gorin; Mohamad Mohty; Arnon Nagler
Journal:  Bone Marrow Transplant       Date:  2020-05-10       Impact factor: 5.483

4.  Matched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMT.

Authors:  Francesco Saraceni; Myriam Labopin; Norbert-Claude Gorin; Didier Blaise; Reza Tabrizi; Liisa Volin; Jan Cornelissen; Jean-Yves Cahn; Patrice Chevallier; Charles Craddock; Depei Wu; Anne Huynh; William Arcese; Mohamad Mohty; Arnon Nagler
Journal:  J Hematol Oncol       Date:  2016-09-02       Impact factor: 17.388

5.  The Clinicopathological Impact of Granulocyte-Macrophage Colony-Stimulating Factor Gene Expression and Different Molecular Prognostic Biomarkers in Egyptian Acute Myeloid Leukemia Patients.

Authors:  Bassant Nagdy; Hebatallah A Kassem; Abdel-Rahman B Abdel-Ghaffar; Dina M Seoudi; Neemat M Kassem
Journal:  Asian Pac J Cancer Prev       Date:  2020-07-01

6.  Somatostatin receptor mediated targeting of acute myeloid leukemia by photodynamic metal complexes for light induced apoptosis.

Authors:  Naidu M Vegi; Sabyasachi Chakrabortty; Maksymilian M Zegota; Seah Ling Kuan; Anne Stumper; Vijay P S Rawat; Stefanie Sieste; Christian Buske; Sven Rau; Tanja Weil; Michaela Feuring-Buske
Journal:  Sci Rep       Date:  2020-01-15       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.